On October 20, 2025, an article published in the journal Med reported exciting advancements in the realm of medical treatment related to a groundbreaking concept known as "enteral ventilation." This innovative approach, which garnered an IgNobel Prize in 2024, investigates the potential of delivering oxygen rectally in cases of airway obstruction or severely compromised lung function.

The Science Behind Enteral Ventilation

This concept proposes a novel enema-like method that uses a super-oxygenated liquid to provide life-sustaining oxygen directly to the bloodstream through the colon. Dr. Takanori Takebe, MD, Ph.D., a prominent figure in organoid medicine, highlighted the significance of the first human clinical trial aimed at assessing the safety of this unconventional technique. According to Takebe:

"This is the first human data, and the results are limited solely to demonstrating the safety of the procedure and not its effectiveness. But now that we have established tolerance, the next step will be to evaluate how effective the process is for delivering oxygen to the bloodstream."

A Promising Foundation

The initial research was conducted on porcine models, which laid the groundwork for this intriguing medical endeavor. This foundational research, which eventually made its way to the general public via a popular Canada-based science television show, emphasized that this low-tech procedure could significantly benefit patients when conventional methods fail.

Applications of Enteral Ventilation

If proven effective, enteral ventilation could offer a critical solution for:

  • Victims with blocked airways due to trauma or inflammation.
  • Patients whose lungs are underperforming due to infections.
  • Individuals experiencing severe respiratory distress from other complications.

Historical Context

The idea of using alternative respiratory methods harkens back decades. Notably, the technique draws inspiration from the loach, a bottom-feeding fish capable of absorbing oxygen through its gut in low-oxygen environments. Furthermore, this approach builds upon earlier research by Leland Clark, Ph.D., who developed a perfluorocarbon liquid known as Oxycyte, which was intended for potential use as artificial blood but never materialized into a viable product. Pop culture has even referenced this concept; the 1989 film The Abyss famously depicted a rat "breathing" liquid oxygen.

Recent Findings from Clinical Trials

The latest study focused on 27 healthy male participants in Japan, each tasked with retaining varying volumes of perfluorocarbon liquid without any oxygenation for a duration of 60 minutes. The results were encouraging:

Volume Retained (ml) Number of Participants Reported Discomfort
Up to 500 10 No discomfort
Up to 1,000 10 Mild discomfort
Up to 1,500 7 Abdominal bloating

No serious adverse events were reported, demonstrating the procedure’s safety in healthy adults. This initial tolerance lays the groundwork for future studies evaluating the efficacy of the process in raising blood oxygen levels.

Next Steps in Research

Following the promising outcomes from the initial trial, researchers are eager to advance to the next phases of the study:

  • Conducting trials utilizing the oxygenated version of the liquid to assess its impact on blood oxygen levels.
  • Determining the optimal volume and duration for effective oxygen delivery.
  • Exploring the application of enteral ventilation in neonatal care to address respiratory issues in newborns.

Dr. Takebe has initiated a company, EVA Therapeutics, to further this project, with the timing of future clinical trials contingent on securing adequate funding.

Conclusion

The concept of “enteral ventilation” presents a fascinating intersection of innovative thinking and biological science. If research continues to show positive results, this method could revolutionize emergency medical practices and improve patient outcomes significantly. As noted by Takebe, the scientific community is excited about the potential of this groundbreaking approach.

Further Reading

For more details, refer to the original study: Safety and Tolerability of Intrarectal Perfluorodecalin for Enteral Ventilation in a First-in-Human Trial, published in Med (2025).

References

1. Takebe, T., et al. (2025). Safety and Tolerability of Intrarectal Perfluorodecalin for Enteral Ventilation in a First-in-Human Trial. Med. DOI: 10.1016/j.medj.2025.100887.

2. Science X. (2025). IgNobel 'Butt Breathing' idea from 2024 moves closer to real treatment. Retrieved from https://medicalxpress.com/news/2025-10-ignobel-butt-idea-closer-real.html.